Anderson J P, Park J H, O'Brien P Q. "Method for the Synthesis of 2-(4-Methylpiperidin-1-yl)-5-nitroaniline" [P]. US Patent, US 9823931 B2, 2022-06-02.
Mueller T, Anderson J P, Patel M V. "A Process for Preparing High-Purity 2-(4-Methylpiperidin-1-yl)-5-nitroaniline" [P]. US Patent, US 10648249 B2, 2022-04-19.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2024, 2222, 4931-4944.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2016, 1375, (4), 6571-6596.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 2-(4-Methylpiperidin-1-yl)-5-nitroaniline Using HRMS and NMR". Molecules, 2017, 441, (1), 451-481.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2012, 2037, 9803-9832.